Santa Monica, California 90404


Purpose:

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)


Study summary:

The purpose of this study is to allow the collection of tissue from subjects to be used in future research studies by scientists and to isolate tumor fighting cells for the future treatment of Melanoma.


Criteria:

Inclusion Criteria: 1. Patients must have metastatic melanoma with a resectable metastasis who are undergoing resection for palliation, therapeutic or curative purpose. 2. Patients must be > 15 years of age and must have metastatic melanoma. 3. Patients must meet standard pre-operative requirements as determined by the surgeon to be candidates for surgery. 4. Patients must be able to understand and sign the Informed Consent document. 5. Patients must be able to complete the supplemental data form Exclusion Criteria: 1. women who are pregnant or breastfeeding 2. inability to give consent


NCT ID:

NCT02339987


Primary Contact:

Principal Investigator
Santosh Kesari, MD, PhD
John Wayne Cancer Institute

Santosh B. Kesari, MD, PhD
Phone: 310-829-8265
Email: KesariS@jwci.org


Backup Contact:

Email: garverk@jwci.org
Kelly Garver
Phone: 310-582-7456


Location Contact:

Santa Monica, California 90404
United States

Kelly P Garver
Phone: 310-582-7456
Email: garverk@jwci.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.